ZA200106181B - 6-O-substituted macrolides having antibacterial acitivity. - Google Patents

6-O-substituted macrolides having antibacterial acitivity. Download PDF

Info

Publication number
ZA200106181B
ZA200106181B ZA200106181A ZA200106181A ZA200106181B ZA 200106181 B ZA200106181 B ZA 200106181B ZA 200106181 A ZA200106181 A ZA 200106181A ZA 200106181 A ZA200106181 A ZA 200106181A ZA 200106181 B ZA200106181 B ZA 200106181B
Authority
ZA
South Africa
Prior art keywords
thienyl
group
substituted
alkyl
aryl
Prior art date
Application number
ZA200106181A
Other languages
English (en)
Inventor
Yat Sun Or
Zhenkun Ma
Richard F Clark
Michael J Rupp
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA200106181B publication Critical patent/ZA200106181B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200106181A 1999-03-15 2001-07-26 6-O-substituted macrolides having antibacterial acitivity. ZA200106181B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27049799A 1999-03-15 1999-03-15

Publications (1)

Publication Number Publication Date
ZA200106181B true ZA200106181B (en) 2002-10-26

Family

ID=23031548

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200106181A ZA200106181B (en) 1999-03-15 2001-07-26 6-O-substituted macrolides having antibacterial acitivity.

Country Status (25)

Country Link
EP (1) EP1161438B1 (ja)
JP (1) JP2002539217A (ja)
KR (1) KR20020008127A (ja)
CN (1) CN1343215A (ja)
AT (1) ATE266036T1 (ja)
AU (1) AU3517700A (ja)
BG (1) BG105865A (ja)
BR (1) BR0008731A (ja)
CA (1) CA2367431C (ja)
CO (1) CO5271742A1 (ja)
CZ (1) CZ20013223A3 (ja)
DE (1) DE60010442T2 (ja)
DK (1) DK1161438T3 (ja)
ES (1) ES2222189T3 (ja)
HK (1) HK1044157A1 (ja)
HU (1) HUP0201067A3 (ja)
IL (1) IL144542A0 (ja)
NO (1) NO20014380L (ja)
NZ (1) NZ513206A (ja)
PL (1) PL350650A1 (ja)
PT (1) PT1161438E (ja)
SK (1) SK13162001A3 (ja)
TR (1) TR200102522T2 (ja)
WO (1) WO2000055168A1 (ja)
ZA (1) ZA200106181B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
TWI246515B (en) * 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
WO2003068791A2 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolides with activity against methicillin-resistant staphylococcus aureus
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
KR101431279B1 (ko) 2005-07-29 2014-08-20 리스버로직스 코퍼레이션 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달
EP2086970B1 (en) * 2006-08-24 2014-02-26 Novartis AG 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders
RU2009114857A (ru) 2006-09-22 2010-10-27 Новартис АГ (CH) Гетероциклические органические соединения
EA200900820A1 (ru) 2006-12-20 2010-02-26 Новартис Аг 2-замещенные 5-членные гетероциклы в качестве ингибиторов стеароил-соа-десатуразы (ссд)
MX2009008099A (es) 2007-02-01 2009-12-14 Resverlogix Corp Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
JP5602728B2 (ja) 2008-06-26 2014-10-08 レスバーロジックス コーポレイション キナゾリノン誘導体の製造方法
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Novel anti-inflammatory agents
SI2421533T1 (sl) 2009-04-22 2019-01-31 Resverlogix Corp. Nova protivnetna sredstva
DK2773354T3 (da) 2011-11-01 2019-08-05 Resverlogix Corp Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
CN104650166B (zh) * 2014-11-17 2017-12-05 广东东阳光药业有限公司 一种大环内酯的制备方法
EP3268007B1 (en) 2015-03-13 2022-11-09 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291351B1 (en) * 1996-09-04 2005-07-13 Abbott Laboratories 6-0 substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців

Also Published As

Publication number Publication date
NO20014380D0 (no) 2001-09-10
NZ513206A (en) 2004-02-27
DE60010442T2 (de) 2005-05-12
CO5271742A1 (es) 2003-04-30
PL350650A1 (en) 2003-01-27
JP2002539217A (ja) 2002-11-19
EP1161438A1 (en) 2001-12-12
KR20020008127A (ko) 2002-01-29
CN1343215A (zh) 2002-04-03
HK1044157A1 (zh) 2002-10-11
AU3517700A (en) 2000-10-04
CA2367431A1 (en) 2000-09-21
NO20014380L (no) 2001-09-10
DK1161438T3 (da) 2004-08-30
HUP0201067A2 (en) 2002-08-28
EP1161438B1 (en) 2004-05-06
HUP0201067A3 (en) 2004-07-28
BR0008731A (pt) 2002-09-24
ES2222189T3 (es) 2005-02-01
SK13162001A3 (sk) 2001-12-03
CZ20013223A3 (cs) 2002-01-16
TR200102522T2 (tr) 2001-12-21
IL144542A0 (en) 2002-05-23
CA2367431C (en) 2008-06-10
DE60010442D1 (de) 2004-06-09
PT1161438E (pt) 2004-09-30
ATE266036T1 (de) 2004-05-15
BG105865A (en) 2002-05-31
WO2000055168A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
US6054435A (en) 6-O-substituted macrolides having antibacterial activity
ZA200106181B (en) 6-O-substituted macrolides having antibacterial acitivity.
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) 6,11-bridged erythromycin derivatives
US5866549A (en) 6-O-substituted ketolides having antibacterial activity
CA2372270C (en) C-2 modified erythromycin derivatives
US5780605A (en) 6,9-bridged erythromycin derivatives
EP1027362B1 (en) 2-halo-6-o-substituted ketolide derivatives
EP1025114B1 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
EP1027361B1 (en) 6,11-bridged erythromycin derivatives
KR19990067492A (ko) 트리사이클릭 에리트로마이신 유도체
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
KR20000057017A (ko) 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도
EP1007530B1 (en) 6-o-substituted erythromycin compounds and method for making same
US6753415B2 (en) 23-O-substituted 5-O-mycaminosyltylonide derivatives
EP1206476B1 (en) 9a-azalides with antibacterial activity
US6727229B2 (en) 11,12-substituted lactone ketolide derivatives having antibacterial activity
CA2301642A1 (en) 3-descladinose 6-o-substituded erythromycin derivatives
US5747466A (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
EP1259923B1 (en) Anti-infective agents useful against mulitidrug-resistant strains of bacteria
MXPA01009290A (en) 6-o-substituted macrolides having antibacterial activity
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives